In this podcast, Dr Katz will discuss one of his recent studies that looked at risk factors for revision surgery after total hip replacement.
Which of your patients is more likely to need revision surgery after total hip replacement?
That’s the question we put to Dr Jeffrey Katz. In the next 5 minutes, Dr Katz will discuss one of his recent studies that looked at risk factors for revision surgery after total hip replacement.
Dr Katz is Professor of Medicine and Orthopedic Surgery, Harvard Medical School. He is a rheumatologist and clinical epidemiologist with over 20 years of clinical and research experience in osteoarthritis and the intersection of osteoarthritis and orthopedic surgery.
For more information: http://www6.aaos.org/news/pemr/releases/release.cfm?releasenum=967
Which of your patients is more likely to need revision surgery after total hip replacement?
FDA Accepts Protocol for Annovis Bio’s Buntanetap Phase 3 Alzheimer Disease Trial
January 9th 2025Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.